COPD trials in Kenya

1 of 1 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

  Where

  Kilifi, Machakos, Nairobi, Thika

  Age

  40 years to 90 years

  People

  2,000 worldwide

  Run by

  Hoffmann-La Roche

  See details and how to joinNCT05878769